By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    How Not to Become a Victim of Medical Scams
    How Not to Become a Victim of Medical Scams
    December 22, 2021
    11 Ways You Can Care for Your Elder Family Members Health
    11 Ways You Can Care for Your Elder Family Members Health
    April 6, 2022
    How Can Brain Injury Lead To Dangerous Long-Term Effects?
    How Can Brain Injury Lead To Dangerous Long-Term Effects?
    August 30, 2022
    Latest News
    3 Ways To Deal With Health Issues In Cities With High Pollution
    March 22, 2023
    What Tools Should Your Caregiver Have?
    March 22, 2023
    How to Combat Home Sickness After Moving Abroad
    March 19, 2023
    4 Ways to Recover from a Broken Hip
    March 14, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Unintended Pregnancy: A Biomarker for Disease and Poverty
    February 13, 2012
    Government Pays Bonuses for Increasing Medicaid Expenditures
    August 26, 2017
    New Report from Alzheimer’s Association Offers “Sobering Statistics” on Disease
    March 10, 2012
    Latest News
    What Are Bioidentical Hormones Made With?
    March 23, 2023
    Cover Medical Costs of Child Dog Bites with Legal Specialists
    March 23, 2023
    3 Ways to Improve the U.S. Healthcare System By 2030
    March 14, 2023
    6 Steps To Ensure Speed And Efficiency Of Clinical Studies
    March 14, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: A High Price for Rare Cancer Drugs
Share
Sign In
Notification Show More
Latest News
The Best Natural Sleep Remedies & Aids
The Best Natural Sleep Remedies & Aids
Wellness
Bioidentical Hormones
What Are Bioidentical Hormones Made With?
Medical Education
chemical peels for skin disorders
Chemical Peels Can Do Wonders for Treating Skin Disorders
Skin
health benefits of lip enhancements
Cleveland Clinic Cites Health Benefits of Lip Enhancements
lifestyle
child dog bite lawyer
Cover Medical Costs of Child Dog Bites with Legal Specialists
News
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > A High Price for Rare Cancer Drugs
BusinessMedical Ethics

A High Price for Rare Cancer Drugs

gooznews
Last updated: 2011/08/31 at 7:07 AM
gooznews
Share
5 Min Read
SHARE

Pfizer last week won Food and Drug Administration “accelerated approval” for Xalkori (crizotinib) for a rare form of metastatic lung cancer that strikes about 3 percent of people — almost always non-smokers — who come down with the disease. That’s about 10,000 patients per year in the U.S., and perhaps a similar number abroad. Multiply that times the $$115,200 a year the company plans to charge for Xalkori, and they’ve got themselves a billion dollar blockbuster.

Pfizer last week won Food and Drug Administration “accelerated approval” for Xalkori (crizotinib) for a rare form of metastatic lung cancer that strikes about 3 percent of people — almost always non-smokers — who come down with the disease. That’s about 10,000 patients per year in the U.S., and perhaps a similar number abroad. Multiply that times the $$115,200 a year the company plans to charge for Xalkori, and they’ve got themselves a billion dollar blockbuster.

What does it mean when a drug earns “accelerated approval”? Unfortunately, too many people think this means that it worked so well that the FDA rushed it to market. That’s not how it works. Accelerated approval, which really should be called interim approval, is reserved for drugs that show promise for treating life-threatening diseases like lung cancer, which is the best way to describe Xalkori.

In two single-arm clinical trials (no comparison arm) involving 255 patients, Xalkori delayed tumor progression for about 10 months in slightly more than half the patients who had a specific genetic mutation. Will it prolong survival? That isn’t known yet. Those findings must await the results of follow-up trials, which will contain a placebo arm and will evaluate the drug’s potential for delaying death, not just the surrogate marker of delayed tumor progression, which may or may not signal improved prospects for survival.

More Read

air pollution and cancer

The Proven Links Between Air Pollution and Cancer

9 Hospitals That Have Introduced Green Initiatives
Best Money-Saving Tips for Health Managers
HR Must Navigate Polarizing Views in Healthcare Workplaces
Should Hospitals Use SASE or Traditional Network Security?

How long will it take for Pfizer to complete those trials? At least a couple of years, since that is the life expectancy of most patients diagnosed with metastatic lung cancer whether they have the particular mutation targeted by Xalkori or not. And it might take a lot longer, since the “excitement” among oncologists (see this MedPage Today story) may make it difficult to recruit patients with that mutation to enter a clinical trial where they have a 50-50 chance of getting a placebo. It’s a ready-made excuse for Pfizer, should it fail to complete the trials in a timely manner, which has happened in a large handful of cases involving cancer drugs given accelerated approval.

Through this period where there will be no concrete proof of efficacy, Pfizer will get to charge an outlandishly high price for the drug. Is there a way to put pressure on the company to complete the trials in a more timely fashion, so that the paying public knows that it is truly getting value for its health care dollar and not subjecting patients to some pretty rough side effects (nausea, diarrhea, etc.) for no benefit? Last October, an article appeared in Health Affairs suggesting that Medicare should only pay the asked price for a drug that has not yet proven its superiority to existing treatments for up to a maximum of three years. If the company doesn’t provide clinical proof justifying the higher price within that time, the authors suggested, Medicare should simply pay the rate charged for the best “proven” therapy, which in cancer chemotherapy, is almost always a generic.

A similar model could be applied to drugs given accelerated approval. Medicare and private insurers could agree to pay the asked $115,200 a year for this drug  for three years, which is a reasonable time to complete the final trials. After that, it should be generic pricing until the company comes up with definitive proof.

TAGGED: cancer, Pfizer, pharmaceuticals

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
gooznews August 31, 2011
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article Childhood Obesity: It’s Everyone’s Business
Next Article Strange Coincidence: When Cancer Strikes Hospital CEO

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

The Best Natural Sleep Remedies & Aids
The Best Natural Sleep Remedies & Aids
Wellness March 23, 2023
Bioidentical Hormones
What Are Bioidentical Hormones Made With?
Medical Education March 23, 2023
chemical peels for skin disorders
Chemical Peels Can Do Wonders for Treating Skin Disorders
Skin March 23, 2023
health benefits of lip enhancements
Cleveland Clinic Cites Health Benefits of Lip Enhancements
lifestyle March 23, 2023

You Might also Like

hair transplants for cancer patients
News

Why Reputable Hair Transplant Clinics Can Help Cancer Patients

March 21, 2023
medical call centers benefits
Wellness

Best Practices for Healthcare Call Centers Should Follow in 2023

February 16, 2023
employee's wellness
Health

How Hospitals and Other Healthcare Providers Can Boost Employee Morale

February 13, 2023
BusinessHospital Administration

What are the Benefits of Hospitals and Clinics Using Expense Management Services?

February 13, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?